Authors:
Lynch, J
Morrison, J
Graves, N
Meddis, D
Drummond, MF
Hellewell, JSE
Citation: J. Lynch et al., The health economic implications of treatment with quetiapine: an audit oflong-term treatment for patients with chronic schizophrenia, EUR PSYCHIA, 16(5), 2001, pp. 307-312
Citation: D. Coyle et Mf. Drummond, Analyzing differences in the costs of treatment across centers within economic evaluations, INT J TE A, 17(2), 2001, pp. 155-163
Citation: Mf. Drummond, Health economic models: a question of balance - summary of an open discussion on the pharmacoeconomic evaluation of non-steroidal anti-inflammatory drugs, RHEUMATOLOG, 39, 2000, pp. 29-32
Citation: O. Sangha et Mf. Drummond, The Swedish ACCES model: predicting the health economic impact of celecoxib in patients with osteoarthritis or rheumatoid arthritis - Concluding remarks, RHEUMATOLOG, 39, 2000, pp. 60-60
Authors:
Mason, JM
Moayyedi, P
Young, PJ
Duffett, S
Crocombe, W
Drummond, MF
Axon, ATR
Citation: Jm. Mason et al., Population-based and opportunistic screening and eradication of Helicobacter pylori - An analysis using trial baseline data, INT J TE A, 15(4), 1999, pp. 649-660
Authors:
Mason, JM
Drummond, MF
Bosanquet, AG
Sheldon, TA
Citation: Jm. Mason et al., The DiSC assay - A cost-effective guide to treatment for chronic lymphocytic leukemia?, INT J TE A, 15(1), 1999, pp. 173-184